These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32354774)

  • 1. Non-steroidal anti-inflammatory treatment during covid-19: friend or foe? Response to: 'Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)' by Giollo
    Monti S; Montecucco C
    Ann Rheum Dis; 2021 Feb; 80(2):e13. PubMed ID: 32354774
    [No Abstract]   [Full Text] [Related]  

  • 2. Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID).
    Giollo A; Adami G; Gatti D; Idolazzi L; Rossini M
    Ann Rheum Dis; 2021 Feb; 80(2):e12. PubMed ID: 32321720
    [No Abstract]   [Full Text] [Related]  

  • 3. In adults, NSAID use vs. nonuse in the past 4 mo was not linked to increased risk for COVID-19-related mortality.
    Varner CE
    Ann Intern Med; 2021 May; 174(5):JC58. PubMed ID: 33939487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study.
    Lund LC; Kristensen KB; Reilev M; Christensen S; Thomsen RW; Christiansen CF; Støvring H; Johansen NB; Brun NC; Hallas J; Pottegård A
    PLoS Med; 2020 Sep; 17(9):e1003308. PubMed ID: 32898149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2 : Anti-inflammatory and anti-fibrotic therapy could solve the lung complications of the infection?
    Ferrara F; Granata G; Pelliccia C; La Porta R; Vitiello A
    Eur J Clin Pharmacol; 2020 Nov; 76(11):1615-1618. PubMed ID: 32594204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Use of Nonsteroidal Anti-inflammatory Drugs in Urological Practice in the COVID-19 Era: Is "Safe Better than Sorry"?
    Pradère B; Ploussard G; Catto JWF; Rouprêt M; Misrai V
    Eur Urol; 2020 Aug; 78(2):134-135. PubMed ID: 32284245
    [No Abstract]   [Full Text] [Related]  

  • 7. [Not Available].
    Göbel H
    MMW Fortschr Med; 2020 Apr; 162(7):18-20. PubMed ID: 32291679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NSAIDs may increase the risk of thrombosis and acute renal failure in patients with COVID-19 infection.
    Cumhur Cure M; Kucuk A; Cure E
    Therapie; 2020; 75(4):387-388. PubMed ID: 32636031
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of non-steroidal anti-inflammatory drugs (NSAIDs) in COVID-19.
    Kushner P; McCarberg BH; Grange L; Kolosov A; Haveric AL; Zucal V; Petruschke R; Bissonnette S
    NPJ Prim Care Respir Med; 2022 Sep; 32(1):35. PubMed ID: 36127354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does use of nonsteroidal anti-inflammatory drugs increase patients' clinical severity of COVID-19?
    de Oliveira HSB
    Sao Paulo Med J; 2021; 139(4):418-419. PubMed ID: 34346964
    [No Abstract]   [Full Text] [Related]  

  • 11. Can an Old Ally Defeat a New Enemy?
    Gurbel PA; Bliden KP; Schrör K
    Circulation; 2020 Jul; 142(4):315-317. PubMed ID: 32478567
    [No Abstract]   [Full Text] [Related]  

  • 12. Biologics, spondylitis and COVID-19.
    Rosenbaum JT; Hamilton H; Choi D; Weisman MH; Reveille JD; Winthrop KL
    Ann Rheum Dis; 2020 Dec; 79(12):1663-1665. PubMed ID: 32522741
    [No Abstract]   [Full Text] [Related]  

  • 13. Patient-Driven Discontinuation of Apremilast During the COVID-19 Pandemic in Two Canadian Academic Hospital Clinics and One Community Practice.
    Georgakopoulos JR; Vender R; Yeung J
    J Cutan Med Surg; 2020; 24(4):418-419. PubMed ID: 32396018
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19 and NSAIDs: Primum non nocere.
    Micallef J; Soeiro T; Jonville-Béra AP
    Therapie; 2020; 75(5):514-515. PubMed ID: 32839015
    [No Abstract]   [Full Text] [Related]  

  • 15. Opportunistic virus infections in psoriasis patients: The safer alternative of apremilast in the COVID-19 era.
    Armesto S; González Vela C; González López MA
    Dermatol Ther; 2020 Jul; 33(4):e13618. PubMed ID: 32424891
    [No Abstract]   [Full Text] [Related]  

  • 16. COMPLEX REASONS TO TREAT COVID-19-RELATED FEVER.
    Verd S; Ponce-Taylor J; López-García M
    J Paediatr Child Health; 2020 Dec; 56(12):2000-2001. PubMed ID: 33351252
    [No Abstract]   [Full Text] [Related]  

  • 17. Covid-19-The real role of NSAIDs in Italy.
    de Girolamo L; Peretti GM; Maffulli N; Brini AT
    J Orthop Surg Res; 2020 May; 15(1):165. PubMed ID: 32366317
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management.
    Mugheddu C; Pizzatti L; Sanna S; Atzori L; Rongioletti F
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e376-e378. PubMed ID: 32385859
    [No Abstract]   [Full Text] [Related]  

  • 19. Unique skin manifestations of COVID-19: Is drug eruption specific to COVID-19?
    Sakaida T; Tanimoto I; Matsubara A; Nakamura M; Morita A
    J Dermatol Sci; 2020 Jul; 99(1):62-64. PubMed ID: 32425356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NSAIDs for analgesia in the era of COVID-19.
    Herzberg DL; Sukumaran HP; Viscusi E
    Reg Anesth Pain Med; 2020 Sep; 45(9):677-678. PubMed ID: 32499385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.